We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Multiplex Nucleic Acid Suspension Bead Array Detects Filoviruses

By LabMedica International staff writers
Posted on 28 Apr 2015
Filoviruses (FVs) are ribonucleic acid (RNA) viruses that belong to the family Filoviridae, which includes zoonotic pathogens of the three genera Ebolavirus (EV), Marburgvirus (MV), and Cuevavirus (CV).

Multiplex suspension bead array systems that allow fast and reliable detection of reverse transcriptase polymerase chain reaction (RT-PCR) amplified filovirus genomes and enabled subtyping of Ebolavirus species and Marburgvirus strains has been described. More...


Scientists at the Public Health Agency of Sweden (Solna, Sweden) and their colleagues set up a multiplex suspension bead array system, by designing two different RT-PCRs that could amplify all known EV and MV species, respectively, based on whole-genome sequences of FVs, including Reston ebolavirus (RESTV), and Bundibugyo ebolavirus (BDBV). The RT-PCRs were performed using a SuperScript III One-Step RT-PCR kit with Platinum Taq (Invitrogen, Carlsbad CA, USA).

The RT-PCR amplicons were also sequenced to confirm specificity. In parallel, different sets of magnetic Bio-Plex Pro COOH beads (Bio-Rad Laboratories, Hercules, CA, USA) were coupled with oligonucleotides specific for each EV species and MV strain. The suspension bead arrays were also tested on human sera spiked with Lassa virus, Dengue virus serotypes 1 to 4, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, and 10 FV-negative human sera. The results did not reveal any cross-reactivity which demonstrated the utility of the microsphere-based assay as a rapid and accurate diagnostic tool for confirming suspected FV infections.

The EV system can distinguish between three EV species and the MV system can distinguish between four MV strains. Based on the sequence information from the current Ebola outbreak in West Africa, the EBOV probe described in the study will also detect that particular strain. The multiplex suspension bead array system developed can easily be adapted to emerging new strains by including additional beads. The study was published in the April 2015 issue of the Journal of Clinical Microbiology.

Related Links:

Public Health Agency of Sweden 
Invitrogen 
Bio-Rad Laboratories 



New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.